Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03340506 |
Title | Dabrafenib and/or Trametinib Rollover Study |
Recruitment | Recruiting |
Gender | both |
Phase | FDA approved |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | child | adult | senior |
Covered Countries | USA | NLD | HUN | FRA | ESP | DNK | DEU | AUT | ARG |